NOTE 18 SEGMENT INFORMATION We are organized into three reporting segments. Operations that sell dispensing systems and sealing solutions primarily to the beauty, personal care and home care markets form the Beauty + Home segment. Operations that sell dispensing systems and sealing solutions to the prescription drug, consumer health care, injectables and active packaging markets form the Pharma segment. Operations that sell dispensing systems and sealing solutions to the food and beverage markets form the Food + Beverage segment. The accounting policies of the segments are the same as those described in Note 1  Summary of Significant Accounting Policies. In order to more closely align with how the markets analyze our segment results, we have changed our non-U.S. GAAP segment measure of profitability from Segment Income to Adjusted EBITDA beginning in 2018. All internal segment reporting and discussions of results with our Chief Operating Decision Maker (CODM) are now based on segment Adjusted EBITDA. All references to segment profitability have been updated for this change. Financial information regarding our reporting segments is shown below:             Year Ended December 31,  2019 2018 2017 Total Sales:           Beauty + Home  $ 1,376,027  $ 1,446,231  $ 1,333,048  Pharma  1,100,463  955,069  805,913  Food + Beverage  418,017  386,689  352,483  Total Sales  $ 2,894,507  $ 2,787,989  $ 2,491,444  Less: Intersegment Sales:           Beauty + Home  $ 23,313  $ 19,849  $ 19,262  Pharma  9,412  417  33  Food + Beverage  2,050  2,962  2,866  Total Intersegment Sales  $ 34,775  $ 23,228  $ 22,161  Net Sales:           Beauty + Home  $ 1,352,714  $ 1,426,382  $ 1,313,786  Pharma  1,091,051  954,652  805,880  Food + Beverage  415,967  383,727  349,617  Net Sales  $ 2,859,732  $ 2,764,761  $ 2,469,283  Adjusted EBITDA (1):           Beauty + Home  $ 181,150  $ 185,926  $ 173,227  Pharma  387,483  343,706  275,933  Food + Beverage  68,108  57,589  62,903  Corporate &amp; Other, unallocated  (44,406)  (36,285)  (37,457)  Acquisition-related costs (2)   (3,927)   (23,770)     Restructuring Initiatives (3)  (20,472)  (63,829)  (2,208)  Gain on insurance recovery (4)         10,648  Depreciation and amortization (5)   (194,552)   (171,747)   (153,094)  Interest Expense   (35,489)   (32,626)   (40,597)  Interest Income  4,174  7,056  5,470  Income before Income Taxes  $ 342,069  $ 266,020  $ 294,825  Depreciation and Amortization:           Beauty + Home  $ 82,778  $ 83,546  $ 79,422  Pharma  65,590  51,495  41,143  Food + Beverage  35,728  27,467  24,720  Corporate &amp; Other  10,456  9,239  7,809  Depreciation and Amortization  $ 194,552  $ 171,747  $ 153,094  Capital Expenditures:           Beauty + Home  $ 96,040  $ 101,371  $ 76,425  Pharma  89,702  54,433  33,005  Food + Beverage  45,130  41,236  38,730  Corporate &amp; Other  13,933  25,739  18,924  Transfer of Corporate Technology Expenditures (6)   (2,529)   (11,527)   (10,460)  Capital Expenditures  $ 242,276  $ 211,252  $ 156,624  Total Assets:           Beauty + Home  $ 1,378,292  $ 1,373,816  $ 1,358,283  Pharma  1,422,815  1,324,696  881,443  Food + Beverage  534,527  501,700  296,271  Corporate &amp; Other  226,485  177,523  601,826  Total Assets  $ 3,562,119  $ 3,377,735  $ 3,137,823  (1) We evaluate performance of our reporting segments and allocate resources based upon Adjusted EBITDA. Adjusted EBITDA is defined as earnings before net interest, taxes, depreciation, amortization, unallocated corporate expenses, restructuring, acquisition-related costs and insurance recoveries. (2) Acquisition-related costs include transaction costs and purchase accounting adjustments related to inventory for acquisitions (see Note 20  Acquisitions for further details). (3) Restructuring Initiatives includes expense items for the years ended December 31, 2019 and 2018 as follows (see Note 21  Restructuring Initiatives for further details):             Year Ended December 31, 2019 2018 2017 Restructuring Initiatives by Segment           Beauty + Home  $ 17,682  $ 52,244  $ 529  Pharma  632  3,589    Food + Beverage  391  4,185  1,679  Corporate &amp; Other   1,767   3,811     Total Restructuring Initiatives  $ 20,472  $ 63,829  $ 2,208   (4) The gain on insurance recovery relates to the Annecy fire (see Note 19  Insurance Settlement Receivable for further details). (5) Depreciation and amortization includes amortization related to acquisition purchase accounting adjustments for backlog. See the reconciliation of Non-U.S. GAAP measures starting on page 22 . (6) The transfer of corporate technology expenditures represents amounts of projects managed by corporate for the benefit of specific entities within each segment. Once the projects are complete, all related costs are allocated from corporate to and paid by the appropriate entity and the associated assets are then depreciated at the entity level.  Geographic Information The following are net sales and long-lived asset information by geographic area and product information for the years ended December 31, 2019, 2018 and 2017:              2019 2018 2017 Net Sales to Unaffiliated Customers (1):           United States  $ 836,768  $ 726,336  $ 642,164  Europe:           France  895,110   862,364   744,856  Germany  452,409   474,369   416,802  Italy  141,867   144,044   131,523  Other Europe  149,083   146,701   132,992  Total Europe  1,638,469   1,627,478   1,426,173  Other Foreign Countries  384,495   410,947   400,946  Total  $ 2,859,732  $ 2,764,761  $ 2,469,283  Property, Plant and Equipment           United States  $ 300,820  $ 265,004  $ 182,434  Europe:           France  338,288   308,250   266,804  Germany  163,782   154,505   163,948  Italy  53,562   54,978   57,080  Other Europe  63,636   59,411   59,963  Total Europe  619,268   577,144   547,795  Other Foreign Countries  167,590   149,465   137,677  Total  $ 1,087,678  $ 991,613  $ 867,906  (1) Sales are attributed to countries based upon where the sales invoice to unaffiliated customers is generated.  No single customer represents 6% or more of our net sales in 2019, 2018 or 2017.